Abstract
Diffuse alveolar hemorrhage (DAH) is a non-infectious pulmonary complication of bone marrow transplantation (BMT) with resultant high mortality. It reportedly occurs primarily in autologous recipients. We examined the incidence of DAH in our center in order to assess potential risk factors and develop preventive strategies. Between 1991 and 1997, 23 cases of DAH occurred in 922 adult patients (2.5%) receiving BMT for hematological malignancy. Strikingly, 12 cases occurred in 1997 with the majority in recipients of allogeneic matched sibling donor stem cells. Treatment with high-dose steroids, 250 mg to 2 g/day, in 15 patients led to transient improvement in 10 patients, but 21 of the 23 patients required mechanical ventilation. Mortality was high with 17 patients (74%) dying a median of 39 days (range 22–47) post transplant; a median of 17 days post onset of DAH (range 5–34). Six patients are alive with a median follow-up of 18 months (range 12–60). No recognizable alteration in supportive care, conditioning regimen, GVHD prophylaxis or cytokine usage was associated with this striking increase in the frequency of DAH after allografting. Further follow-up is required to establish whether this increase in the incidence of DAH in allogeneic transplantation is an isolated occurrence or an ongoing problem. If indeed there is a real increase in the incidence of this complication, then efforts need to be directed towards elucidating a possible cause or risk factors. We offer the possibility that a new unidentified infection, undetected by current microbiological tests might contribute to this striking increase in DAH. These data, while not establishing a cause, suggest a markedly augmented risk of DAH in allogeneic BMT. In addition, high-dose corticosteroids have only limited efficacy as therapy for DAH after allotransplantation. Further investigation into the pathogenesis of this syndrome is essential as is prompt and immediate consideration of DAH in all patients with respiratory compromise early after BMT. Bone Marrow Transplantation (2000) 26, 539–543.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Soubani AO, Miller KB, Hassoun PM . Pulmonary complications of bone marrow transplantation Chest 1996 109: 1066–1077
Robbins RA, Linder J, Stahl MG et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Am J Med 1989 87: 511–518
Chao NJ, Duncan SR, Long GD et al. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Ann Intern Med 1991 114: 145–146
Mulder POM, Meinesz AF, de Vries EGE, Mulder NH . Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients Am J Med 1991 90: 278–280
Jules-Elysee K, Stover DE, Yahalom J et al. Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone marrow transplantation Am Rev Respir Dis 1992 146: 485–491
Witte RJ, Gurney JW, Robbins RA et al. Diffuse pulmonary alveolar hemorrhage after bone marrow transplantation: radiographic findings in 39 patients Am J Radiol 1991 157: 461–464
Kahn FW, Jones JM, England DM . Diagnosis of pulmonary hemorrhage in the immunocompromised host Am Rev Respir Dis 1987 136: 155–160
Sinning JG, Chao NJ, Long GD et al. Diffuse alveolar hemorrhage following allogeneic bone marrow and blood hematopoietic cell transplantation Blood 1997 90: 252a (Abstr.)
Nevo S, Swan V, Enger C et al. Acute bleeding after bone marrow transplantation (BMT) – incidence and effect on survival. A quantitative analysis in 1,402 patients Blood 1998 91: 1469–1477
Carrigan DR, Drobyski WR, Russler SK et al. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation Lancet 1991 338: 147–149
Cone RW, Hackman RC, Meei-Li WH et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation New Engl J Med 1993 329: 156–161
Kane JR, Shenep JL, Krance RA, Hurwitz CA . Diffuse alveolar hemorrhage associated with mycoplasma hominis respiratory tract infection in a bone marrow transplant recipient Chest 1994 105: 1891–1892
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lewis, I., DeFor, T. & Weisdorf, D. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 26, 539–543 (2000). https://doi.org/10.1038/sj.bmt.1702546
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702546
Keywords
This article is cited by
-
Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage
Bone Marrow Transplantation (2015)
-
Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer
Journal of Intensive Care (2014)